Journal
CURRENT OPINION IN IMMUNOLOGY
Volume 15, Issue 5, Pages 499-506Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/S0952-7915(03)00098-0
Keywords
-
Categories
Ask authors/readers for more resources
Long-term allograft survival in the absence of continuous immunosuppression can be induced following a short treatment of nondepleting antibodies, such as those that target CD4 or CD154 (CD40 ligand). It is now established that this may involve dominant tolerance mechanisms that are maintained by CD4(+) regulatory T cells present within the lymphoid tissue and the tolerated graft. The phenotype of these cells, their relationship to CD4(+)CD25(+) T cells, and the mechanism of action are still controversial.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available